Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous versus topical lidocaine versus remifentanil for hemodynamic control during tracheal intubation in uncontrolled hypertension
IRCT20141009019470N116Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of lidocaine and remifentanil in hypertension (HTN) (3 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Blood pressure. Started Apr 2021; status: completed.
02
Drugs
lidocaineremifentanil
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on IRCT20141009019470N116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141009019470N116.